I agree it's not IHUB, but with so much in the line of defaulted debt with respect to convertible notes that must be taken into consideration for the volume surge also.
It would be better if these items were not in the 10q...they could be discounted and this could solely be a volume surge based on some significant event that somebody is buying into.
Maybe it is, who knows, that would be great and this could be a big gainer. But this company really does have a bunch of triggers that could lead to a huge influx of volume and dilution at any time.
I hope it works out.
It would be better if these items were not in the 10q...they could be discounted and this could solely be a volume surge based on some significant event that somebody is buying into.
Maybe it is, who knows, that would be great and this could be a big gainer. But this company really does have a bunch of triggers that could lead to a huge influx of volume and dilution at any time.
I hope it works out.
Recent INBP News
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/17/2026 08:17:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 04:09:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 03:58:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 03:21:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 07:35:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 04:24:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 09:26:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 07:39:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 09:23:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:56 PM
- Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025 • ACCESS Newswire • 02/11/2026 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/11/2026 09:24:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:25:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:09:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 10:16:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 08:54:53 PM
- Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 • ACCESS Newswire • 11/10/2025 08:50:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/10/2025 08:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/28/2025 01:04:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2025 07:42:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/23/2025 07:23:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2025 06:12:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2025 06:12:04 PM



